Cargando…
Interleukin-1β and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis
BACKGROUND: Multiple sclerosis (MS) has been mainly attributed to white matter (WM) pathology. However, recent evidence indicated the presence of grey matter (GM) lesions. One of the principal mediators of inflammatory processes is interleukin-1β (IL-1β), which is known to play a role in MS pathogen...
Autores principales: | Prins, Marloes, Eriksson, Charlotta, Wierinckx, Anne, Bol, John G. J. M., Binnekade, Rob, Tilders, Fred J. H., Van Dam, Anne-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871572/ https://www.ncbi.nlm.nih.gov/pubmed/24376764 http://dx.doi.org/10.1371/journal.pone.0083835 |
Ejemplares similares
-
Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients
por: Prins, Marloes, et al.
Publicado: (2014) -
Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter
por: Espitia Pinzon, Nathaly, et al.
Publicado: (2014) -
Tissue Transglutaminase Appears in Monocytes and Macrophages but Not in Lymphocytes in White Matter Multiple Sclerosis Lesions
por: Chrobok, Navina L, et al.
Publicado: (2019) -
A functional interleukin-1 type 1 receptor on rat brain endothelial cells
por: Van Dam, A.-M., et al.
Publicado: (1994) -
Concurrent analysis of white matter bundles and grey matter networks in the chimpanzee
por: Mars, Rogier B., et al.
Publicado: (2018)